No Data
No Data
No Data
No Data
No Data
Express News | Changchun Hi-Tech: Net profit of 859 million yuan in the first quarter of 2024 increased 0.2% year-on-year
BreakingsApr 19 16:21
Changchun Hi-Tech (000661.SZ): Application for marketing of injectable triprorelin acetate microspheres accepted
Gelonghui, April 18 | Changchun Hi-Tech (000661.SZ) announced, Changchun Hi-Tech (000661.SZ) announced that the subsidiary Changchun Jinsai Pharmaceutical Co., Ltd. received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's marketing application for injectable triprorelin acetate microspheres was accepted. The company's injectable triprorelin acetate microsphere products improve drug safety by improving drug release characteristics, optimizing prescriptions and processes, and making it possible for pediatric patients to administer fixed doses. A more convenient method of administration supported by evidence-based medical evidence will be central precocious puberty (C
Gelonghui FinanceApr 18 20:15
Heavy warehouse bought back Meituan Kuaishou! Zhong Geng Qiu Dongrong's quarterly report revealed that there were many moves to adjust positions
Early this morning, Qiu Dongrong's products revealed a quarterly report.
聰明投資者Apr 16 11:45
Express News | Qiu Dongrong bought gold stocks in the first quarter
BreakingsApr 16 09:08
Changchun Hi-Tech (000661.SZ) plans to pay 45 yuan for 10 shares to be deducted from interest on April 18
Changchun Hi-Tech (000661.SZ) announced that the company's 2023 equity distribution plan: 45 yuan (tax included) for every 10 shares; the exclusion date is: April 18, 2024.
Zhitong FinanceApr 11 20:56
Express News | Changchun Hi-Tech: Subsidiary's application for marketing of injectable kinazumab accepted
BreakingsApr 11 20:44
No Data
No Data